1424-71-1

Upstream product

• 50-00-0 formaldehyd 
• 1424-70-0 1-(4-pentynyl)-3-methoxybenzene 
• 109-89-7 diethylamine 
• 7252-82-6 3-(3-methoxyphenyl)propan-1-ol 
• 6943-97-1 (m-methoxyphenyl)propyl bromide 
• 10516-71-9 3-(3-Methoxy-phenyl)-propionic acid 
• 123-91-1 1,4-dioxane 
• 188680-60-6 trioxane 

Downstream Products

• 41214-29-3 1-(m-Methoxyphenyl)-hexa-4,5-dien 
• 4209-95-4 6-(m-methoxyphenyl)-1-(2-methyl-1,3-dioxocyclopent-2-yl)hexan-3-one 
• 1229-32-9 (+/-)-3-methoxyestra-1,3,5⁽¹⁰⁾,6,8-pentaen-17-one 
• 1424-75-5 2-(6-m-methoxyphenyl-3-oxohexyl)-2-methylcyclohexane-1,3-dione 
• 1159-08-6 1β-Hydroxy-8β-methyl-4-(3-methoxy-phenethyl)-5,6,7,8-tetrahydro-indanon-(5) 
• 966-46-1 rac-3-Methoxy-1,3,5⁽¹⁰⁾,9⁽¹¹⁾-oestratetraen-17-on 
• 18300-15-7 3-methoxy-9,10-secoestra-1,3,5⁽¹⁰⁾,8⁽¹⁴⁾-tetraene-9,17-dione 
• 1444-59-3 6-(m-methoxyphenyl)hex-1-en-3-one 
• 21506-72-9 10-Methyl-1-(3-methoxy-phenethyl)-2,5-dioxo-Δ¹⁽⁹⁾-octalin 

Relevant academic research and scientific papers

Synthesis of gon-4-enes

1. A therapeutic composition having progestational activity comprising as active ingredient a 17-aliphatic carboxylic acid ester of 17α-ethynyl-18-methyl-19-nortestosterone and a pharmaceutical carrier for said compound.

Synthesis of 13-alkyl-gon-4-ones

The preparation of 13-methylgon-4-enes and novel 13-polycarbonalkylgon-4-enes by a new total synthesis is described. 13-Alkylgon-4-enes having progestational, anabolic and androgenic activities are prepared by forming a tetracylic gonane structure unsaturated in the 1,3,5(10),9(11) and 14-positions, selectively reducing in the B- and C-rings, and converting the aromatic A-ring compounds so-produced to gon-4-enes by Birch reduction and hydrolysis.